Table 2.
Percentage susceptibility of MRSA isolates from the studied hospitals to the antibiotics tested by disc diffusion according to CLSI standards
| Hospital code | FD | GAT | GEN | LZD | MUP | Q/D | SXT | CHL |
| A (179) | 3.4 | 84.9 | 36.1 | 97.8 | 74.3 | 100 | 20.1 | 68.7 |
| B (72) | 1.4 | 88.9 | 44.4 | 84.7 | 73.6 | 100 | 45.8 | 95.8 |
| C (69) | 2.9 | 87.0 | 68.1 | 92.8 | 88.4 | 100 | 66.7 | 91.3 |
| D (64) | 3.1 | 56.3 | 9.4 | 100 | 76.6 | 100 | 12.5 | 85.9 |
| E (74) | 9.5 | 52.7 | 29.7 | 94.6 | 71.6 | 100 | 31.1 | 71.6 |
| F (54) | 7.4 | 96.3 | 57.4 | 98.1 | 83.3 | 100 | 50 | 90.7 |
FD = fusidic acid, GAT = gatifloxacin, GEN = gentamicin, LZD = linezolid, MUP = mupirocin, Q/D = quinupristin/dalfopristin, SXT = sulfamethoxazole/trimethoprim, CHL = chloramphenicol.